Results 111 to 120 of about 26,046 (277)

Investigational antiarrhythmic agents: promising drugs in early clinical development

, 2017
Introduction: Although there have been important technological advances for the treatment of cardiac arrhythmias (e.g., catheter ablation technology), antiarrhythmic drugs (AADs) remain the cornerstone therapy for the majority of patients with ...
Shokoufeh Ghezelbash, Dobromir Dobrev, Heijman, Jordi; id_orcid, Ghezelbash, Shokoufeh, Jordi Heijman, Heijman, Jordi, Dobrev, Dobromir   +6 more
core   +1 more source

Burden and Risk Factors of CGM‐Detected Hypoglycemia in Older Adults With Type 2 Diabetes

Journal of the American Geriatrics Society, EarlyView.
Among older adults with diabetes using insulin or sulfonylureas, the median time spent in hypoglycemia was 3.4% and ~66% of participants exceeded the target of < 1% time with CGM glucose < 70 mg/dL. ABSTRACT Background Comprehensive data on the burden of biochemical hypoglycemia in older adults with type 2 diabetes are lacking.
Michael Fang, Natalie Rula Daya, Yein Jeon, Justin B. Echouffo‐Tcheugui, B. Gwen Windham, Scott Zeger, Elizabeth Selvin   +6 more
wiley   +1 more source

The Effect of Sacubitril/Valsartan on Supraventricular and Ventricular Arrhythmias in Patients With Heart Failure

Annals of Noninvasive Electrocardiology
Background Patients with heart failure with reduced ejection fraction (HFrEF) frequently experience electrical disturbances, such as ventricular or atrial fibrillation (AF).
Alireza Arzhangzadeh, Mohammad Hossein Nikoo, Majid Haghjoo, Fatemeh Rasekh, Shayan Shojaei, Asma Mousavi, Salma Nozhat, Roozbeh Narimani‐Javid, Helia Bazroodi, Sana Neisi, Mitra Mojibpour, Mohammad Abedini, Saghi Eslamzadeh, Hamed Bazrafshan Drissi, Sasan Shafiei   +14 more
doaj   +1 more source

Present and future of antiarrhythmic therapy for atrial fibrillation: A review

Consilium Medicum
Despite the emergence and active development of interventional methods for the treatment of arrhythmias, to date, the use of antiarrhythmic drugs to recover and maintain sinus rhythm is the most significant and in demand in patients with paroxysmal and ...
Aida I. Tarzimanova
doaj   +1 more source

A survey of long-term antiarrhythmic therapy in elderly patients with atrial fibrillation

, 2001
Aim: To investigate the use of long-term antiarrhythmic (rhythm-control [RHY] and rate-control [RAC]) therapy for the management of atrial fibrillation (AF) in elderly patients.
Ines Krass, Ogle, SJ, Shenfield, GM, Gillian M Shenfield, Krass, I, Bajorek, BV, Duguid, MJ, Susan J Ogle, Beata V Bajorek, Margaret J Duguid   +9 more
core   +1 more source

Food Insecurity Among Medicare Beneficiaries in 2017–2022: A Longitudinal Cohort Study

Journal of the American Geriatrics Society, EarlyView.
ABSTRACT Background Food insecurity affects many older adults and is associated with a range of adverse health outcomes. However, most prior research has relied on cross‐sectional data, and evidence on predictors of subsequent food insecurity among Medicare beneficiaries remains limited. Methods We conducted a retrospective longitudinal cohort study of
David D. Kim, Charles J. Duncan, Elliott Crummer   +2 more
wiley   +1 more source

Electrical storm after cardiac resynchronization therapy in a patient with nonischemic cardiomyopathy: Signal‐averaged vector‐projected 187‐channel electrocardiogram‐based risk stratification for lethal arrhythmia

Journal of Arrhythmia, 2013
We describe treatment of atrial flutter and electrical storm presenting as incessant ventricular tachycardia (VT) after implantation of a cardiac resynchronization therapy defibrillator (CRT‐D) in a patient with dilated cardiomyopathy.
Toshiko Nakai, Hiroaki Mano, Yukitoshi Ikeya, Kazumasa Sonoda, Sonoko Ashino, Yasuo Okumura, Kimie Ohkubo, Satoshi Kunimoto, Yuji Kasamaki, Ichiro Watanabe, Atsushi Hirayama, Kenji Nakai   +11 more
doaj   +1 more source

Development of Antiarrhythmic Therapy-Resistant Ventricular Tachycardia, Ventricular Fibrillation, and Premature Ventricular Contractions in a 15-Year-Old Patient. [PDF]

J Pediatr Intensive Care, 2022
Yozgat CY, Yesilbas O, Iscan A, Yurtsever I, Temur HO, Bayramova N, Ergun G, Tekin N, Yozgat Y.   +8 more
europepmc   +1 more source

A preliminary assessment of the effects of ATI-2042 in subjects with paroxysmal atrial fibrillation using implanted pacemaker methodology

, 2009
Aims ATI-2042 (budiodarone) is a chemical analogue of amiodarone with a half life of 7 h. It is electrophysiologically similar to amiodarone, but may not have metabolic and interaction side effects.
Camm, AJ, Arya, A, Milner, P, Silberbauer, J, Sulke, N, Teichman, SL   +5 more
core   +1 more source

Amiodarone‐related thyroid dysfunction and associated outcomes in patients with heart failure—A nationwide cohort study

Journal of Internal Medicine, EarlyView.
Abstract Aim Amiodarone increases the risk of thyroid dysfunction, but the prognostic significance of this complication in patients with heart failure (HF) is uncertain. This study investigates the association between amiodarone‐related thyroid dysfunction and risk of HF hospitalization or death in a nationwide cohort.
Søren Lund Kristensen, Sam Aiyad Ali, Mads Ersbøll, Jawad Haider Butt, Rasmus Rørth, Lucas Malta Westergaard, Lauge Østergaard, Finn Gustafsson, Oren Caspi, Emil Fosbøl, Lars Køber, Christian Selmer   +11 more
wiley   +1 more source